42 research outputs found

    Rollerball microendoscope for mosaicking in high-resolution oral imaging

    Get PDF
    Only 40% of oral cancers are diagnosed at an early, localized stage, when treatment is most effective [1]. Thus, implementing diagnostic imaging tools for early detection of highgrade dysplasia and cancer may help improve the survival rate of oral cancer patients [2]. The highresolution microendoscope (HRME) is a compact, portable, fiberbased imaging device that can image cell nuclei in tissue labeled with the fluorescent contrast agent proflavine [3]. The HRME allows clinicians to noninvasively image the size, shape and distribution of epithelial cell nuclei in vivo, enabling realtime evaluation of potentially neoplastic lesions [3]. The primary limitation of the HRME is the small field of view of its fiber probe (720 μm), which makes it timeconsuming to examine large areas of tissue. Mosaicking algorithms have previously been implemented to allow realtime generation of image mosaics during HRME imaging, thus interrogating a larger field of view than the fiber probe’s diameter [4]. However, this approach has had limited success in vivo due to the practical difficulty of translating the fiber probe across the tissue in a smooth, controlled manner in order for the mosaicking software to function properly. Here we report the construction and initial testing of a rollerball HRME probe that permits smooth, rolling translation across the tissue surface while maintaining image quality with subcellular resolution. The rollerball HRME consists of a standard HRME probe interfaced with a rollerball mechanism. The mechanism is composed of two 5mm sapphire ball lenses enclosed within a 3D printed penlike casing. The ball lenses serve as an optical relay, while the distal ball lens also serves as a rolling contact point with the tissue surface. Figure 1 shows the use of the rollerball HRME to generate a realtime mosaic of a calibration target (field finder slide) as it rolls across the surface of the target. Figure 2 shows the use of the rollerball HRME to generate a realtime mosaic showing cell nuclei on the lateral tongue of a healthy volunteer as it rolls across the tissue surface. The rollerball HRME will allow clinicians to more rapidly examine large areas of tissue with subcellular resolution, potentially aiding in the early detection of highgrade oral dysplasia and cance. Please click Additional Files below to see the full abstract

    Accuracy of In Vivo Multimodal Optical Imaging for Detection of Oral Neoplasia

    Get PDF
    If detected early, oral cancer is eminently curable. However, survival rates for oral cancer patients remain low, largely due to late-stage diagnosis and subsequent difficulty of treatment. To improve cliniciansï¾’ ability to detect early disease and to treat advanced cancers, we developed a multimodal optical imaging system (MMIS) to evaluate tissue in situ, at macroscopic and microscopic scales. The MMIS was used to measure 100 anatomic sites in 30 patients, correctly classifying 98% of pathologically confirmed normal tissue sites, and 95% of sites graded as moderate dysplasia, severe dysplasia, or cancer. When used alone, MMIS classification accuracy was 35% for sites determined by pathology as mild dysplasia. However, MMIS measurements correlated with expression of candidate molecular markers in 87% of sites with mild dysplasia. These findings support the ability of noninvasive multimodal optical imaging to accurately identify neoplastic tissue and premalignant lesions. This in turn may have considerable impact on detection and treatment of patients with oral cancer and other epithelial malignancies

    Multispectral optical imaging device for in vivo detection of oral neoplasia

    Get PDF
    A multispectral digital microscope (MDM) is designed and constructed as a tool to improve detection of oral neoplasia. The MDM acquires in vivo images of oral tissue in fluorescence, narrow-band (NB) reflectance, and orthogonal polarized reflectance (OPR) modes, to enable evaluation of lesions that may not exhibit high contrast under standard white light illumination. The device rapidly captures image sequences so that the diagnostic value of each modality can be qualitatively and quantitatively evaluated alone and in combination. As part of a pilot clinical trial, images are acquired from normal volunteers and patients with precancerous and cancerous lesions. In normal subjects, the visibility of vasculature can be enhanced by tuning the reflectance illumination wavelength and polarization. In patients with histologically confirmed neoplasia, we observe decreased blue/green autofluorescence and increased red autofluorescence in lesions, and increased visibility of vasculature using NB and OPR imaging. The perceived lesion borders change with imaging modality, suggesting that multimodal imaging has the potential to provide additional diagnostic information not available using standard white light illumination or by using a single imaging mode alone.NIH (R21 DE 16485; R01 CA 103830

    A Fiber-Optic Fluorescence Microscope Using a Consumer-Grade Digital Camera for In Vivo Cellular Imaging

    Get PDF
    BACKGROUND: Early detection is an essential component of cancer management. Unfortunately, visual examination can often be unreliable, and many settings lack the financial capital and infrastructure to operate PET, CT, and MRI systems. Moreover, the infrastructure and expense associated with surgical biopsy and microscopy are a challenge to establishing cancer screening/early detection programs in low-resource settings. Improvements in performance and declining costs have led to the availability of optoelectronic components, which can be used to develop low-cost diagnostic imaging devices for use at the point-of-care. Here, we demonstrate a fiber-optic fluorescence microscope using a consumer-grade camera for in vivo cellular imaging. METHODS: The fiber-optic fluorescence microscope includes an LED light, an objective lens, a fiber-optic bundle, and a consumer-grade digital camera. The system was used to image an oral cancer cell line labeled with 0.01% proflavine. A human tissue specimen was imaged following surgical resection, enabling dysplastic and cancerous regions to be evaluated. The oral mucosa of a healthy human subject was imaged in vivo, following topical application of 0.01% proflavine. FINDINGS: The fiber-optic microscope resolved individual nuclei in all specimens and tissues imaged. This capability allowed qualitative and quantitative differences between normal and precancerous or cancerous tissues to be identified. The optical efficiency of the system permitted imaging of the human oral mucosa in real time. CONCLUSION: Our results indicate this device as a useful tool to assist in the identification of early neoplastic changes in epithelial tissues. This portable, inexpensive unit may be particularly appropriate for use at the point-of-care in low-resource settings

    Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions

    No full text
    Potentially premalignant oral epithelial lesions (PPOELs) are a group of clinically suspicious conditions, of which a small percentage will undergo malignant transformation. PPOELs are suboptimally diagnosed and managed under the current standard of care. Dysplasia is the most well-established marker to distinguish high-risk PPOELs from low-risk PPOELs, and performing a biopsy to establish dysplasia is the diagnostic gold standard. However, a biopsy is limited by morbidity, resource requirements, and the potential for underdiagnosis. Diagnostic adjuncts may help clinicians better evaluate PPOELs before definitive biopsy, but existing adjuncts, such as toluidine blue, acetowhitening, and autofluorescence imaging, have poor accuracy and are not generally recommended. Recently, in vivo microscopy technologies, such as high-resolution microendoscopy, optical coherence tomography, reflectance confocal microscopy, and multiphoton imaging, have shown promise for improving PPOEL patient care. These technologies allow clinicians to visualize many of the same microscopic features used for histopathologic assessment at the point of care
    corecore